Management Team « back


Hans van Houte

Chief Financial Officer

Hans van Houte has served as our Chief Financial Officer since June 2020 and has led the finance team at Nurix since 2015. Prior to joining Nurix, Mr. van Houte was a managing partner at Bionation LLC, a financial consulting firm, and served as acting CFO for multiple new biotechnology companies formed with investments totaling over $150 million from Third Rock Ventures and The Column Group. Mr. van Houte previously held senior financial roles in biotechnology companies including Vice President, Finance and Operations at Trubion Pharmaceuticals, Inc., where he was part of the team that took Trubion public in October 2006. Prior to Trubion, Mr. van Houte was the Controller, Treasurer, and Principal Accounting Officer at Vertex Pharmaceuticals, where he helped build the financial and accounting organization post-IPO to support growth from a $100 million to a multibillion market capitalization. Mr. van Houte holds a B.S. in Business Administration, Finance and Accounting from Babson College.